Novel drug prevents common viral disease in stem-cell transplant patients

In a paper in the Sept. 26 issue of the New England Journal of Medicine , the researchers report that patients who took the drug CMX001 shortly after transplant were far less likely to develop cytomegalovirus infection than were patients who took a placebo.

http://www.sciencedaily.com/releases/2013/09/130925185432.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily+%28ScienceDaily%3A+Latest+Science+News%29